Patents by Inventor Greg Thomas

Greg Thomas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of using diketopiperazines and composition containing them
    Patent number: 8455517
    Abstract: The invention provides a method of inhibiting the effects of platelet activating factor (PAF). For instance, a disease or condition mediated by PAF (particularly inflammation) can be treated or platelet aggregation can be inhibited. The invention also provides a method of inhibiting the production and/or release of interleukin 8 (IL-8) by cells. The effects of PAF and the production and/or release of IL-8 are inhibited according to the invention by a compound of the formula: wherein R1 and R2 are defined in the application, or a physiologically-acceptable salt thereof. The invention also provides pharmaceutical compositions comprising these compounds.
    Type: Grant
    Filed: March 25, 2003
    Date of Patent: June 4, 2013
    Assignee: DMI Acquisition Corp.
    Inventors: David Bar-Or, C. Gerald Curtis, Nagaraja K. R. Rao, Greg Thomas
  • SYSTEM AND METHOD FOR MONITORING AND REPORTING ENERGY RECOVERY VENTILATOR STATUS
    Publication number: 20130124111
    Abstract: An energy recovery ventilator (ERV) monitoring and reporting system and a method of monitoring and reporting information on an ERV. In one embodiment, the system includes: (1) a processor configured to carry out a plurality of monitoring and reporting functions on the ERV based on a model, and types and locations of sensors, of the ERV, (2) a memory coupled to the processor and configured to store data gathered from the sensors and (3) a commissioning database associated with the memory and configured to contain commissioning data regarding the model of the ERV.
    Type: Application
    Filed: November 10, 2011
    Publication date: May 16, 2013
    Applicant: Lennox Industries Inc.
    Inventors: Justin McKie, Eric Perez, Greg Thomas
  • Method of using diketopiperazines and composition containing them
    Patent number: 8440696
    Abstract: The invention provides a method of inhibiting the effects of platelet activating factor (PAF). For instance, a disease or condition mediated by PAF (particularly inflammation) can be treated or platelet aggregation can be inhibited. The invention also provides a method of inhibiting the production and/or release of interleukin 8 (IL-8) by cells. The effects of PAF and the production and/or release of IL-8 are inhibited according to the invention by a compound of the formula: wherein R1 and R2 are defined in the application, or a physiologically-acceptable salt thereof. The invention also provides pharmaceutical compositions comprising these compounds.
    Type: Grant
    Filed: September 29, 2011
    Date of Patent: May 14, 2013
    Assignee: DMI Acquisition Corp.
    Inventors: David Bar-Or, C. Gerald Curtis, Nagaraja K. R. Rao, Greg Thomas
  • SYSTEM AND METHOD FOR MONITORING AND REPORTING ENERGY RECOVERY VENTILATOR POWER CONSUMPTION AND SERVICE AND MAINTENANCE NEEDS
    Publication number: 20130116951
    Abstract: A system for, and method of, monitoring and reporting ERV power consumption and service and maintenance needs. In one embodiment, the system includes: (1) a processor configured to carry out a plurality of monitoring and reporting functions related to ERV power consumption and service and maintenance needs based on a model, and types and locations of sensors, of the ERV, (2) a memory coupled to the processor and configured to store data gathered from the sensors and (3) a commissioning database associated with the memory and configured to contain commissioning data regarding the model of the ERV and the service and maintenance needs.
    Type: Application
    Filed: November 9, 2011
    Publication date: May 9, 2013
    Applicant: Lennox Industries Inc.
    Inventors: Justin McKie, Eric Perez, Greg Thomas
  • METHODS OF OPERATING AN HVAC SYSTEM, AN HVAC SYSTEM AND A CONTROLLER THEREFOR EMPLOYING A SELF-CHECK SCHEME AND PREDETERMINED OPERATING PROCEDURES ASSOCIATED WITH OPERATING UNITS OF AN HVAC SYSTEM
    Publication number: 20130090769
    Abstract: In one aspect, a controller for an HVAC system is disclosed. In one embodiment, the controller includes: (1) an interface configured to receive feedback data from operating units of the HVAC system and transmit control data to the operating units, (2) an operation verifier configured to determine an individual operating status for each one of the operating units based on the feedback data and (3) a mode setter configured to distinctly operate each one in a predetermined operating procedure based on the determined operating status for each one.
    Type: Application
    Filed: October 6, 2011
    Publication date: April 11, 2013
    Applicant: Lennox Industries Inc.
    Inventors: Justin McKie, Eric Perez, Greg Thomas
  • DETECTING AND CORRECTING ENTHALPY WHEEL FAILURE MODES
    Publication number: 20130087302
    Abstract: A heating ventilation and cooling system includes an energy recovery ventilator (ERV). The ERV is configured to produce an inlet airstream and an exhaust airstream. An enthalpy wheel within the energy recovery ventilator is operable to transport heat between the inlet and exhaust airstreams. A pressure transducer is configured to determine a backpressure across the enthalpy wheel. A controller is configured to determine, in response to the backpressure, an operational characteristic of the enthalpy wheel.
    Type: Application
    Filed: October 6, 2011
    Publication date: April 11, 2013
    Applicant: Lennox Industries Inc.
    Inventors: Justin McKie, Eric Perez, Greg Thomas, Steve Schneider
  • Mattress and bolster system
    Publication number: 20120297540
    Abstract: An inflatable mattress and bolster assembly in which the mattress frame receives a series of individual inflatable air cells to form the mattress. Side bolsters are secured to the opposite long sides of the mattress frame by means of retaining straps. The air cells have end tabs that pass through holes in the side bolsters and attach the air cells to the long sides of the mattress frame. An inflatable safety rail is mounted on top of each of the side bolsters for added patient safety. The air cells, side bolsters and safety rails are all independently inflated so that they can be separately adjusted for firmness.
    Type: Application
    Filed: May 24, 2011
    Publication date: November 29, 2012
    Inventors: Greg Thomas, John Joseph Pelosi, John Laverack
  • Method of using diketopiperazines and composition containing them
    Patent number: 8268830
    Abstract: The invention provides a method of inhibiting the effects of platelet activating factor (PAF). For instance, a disease or condition mediated by PAF (particularly inflammation) can be treated or platelet aggregation can be inhibited. The invention also provides a method of inhibiting the production and/or release of interleukin 8 (IL-8) by cells. The effects of PAF and the production and/or release of IL-8 are inhibited according to the invention by a compound of the formula: wherein R1 and R2 are defined in the application, or a physiologically-acceptable salt thereof. The invention also provides pharmaceutical compositions comprising these compounds.
    Type: Grant
    Filed: December 28, 2011
    Date of Patent: September 18, 2012
    Inventors: David Bar-Or, C. Gerald Curtis, Nagaraja K. R. Rao, Greg Thomas
  • Tannate compositions, methods of making and methods of use
    Patent number: 8257746
    Abstract: Tannate compositions containing active pharmaceutical ingredients to be used for treating nausea, vomiting, pain, convulsions, and insomnia and manufacturing processes for preparing the tannate compositions.
    Type: Grant
    Filed: July 28, 2011
    Date of Patent: September 4, 2012
    Assignee: Pernix Therapeutics, LLC
    Inventors: Jeffrey S. Kiel, H. Greg Thomas, Narasimhan Mani
  • METHOD OF USING DIKETOPIPERAZINES AND COMPOSITION CONTAINING THEM
    Publication number: 20120094893
    Abstract: The invention provides a method of inhibiting the effects of platelet activating factor (PAF). For instance, a disease or condition mediated by PAF (particularly inflammation) can be treated or platelet aggregation can be inhibited. The invention also provides a method of inhibiting the production and/or release of interleukin 8 (IL-8) by cells. The effects of PAF and the production and/or release of IL-8 are inhibited according to the invention by a compound of the formula: wherein R1 and R2 are defined in the application, or a physiologically-acceptable salt thereof. The invention also provides pharmaceutical compositions comprising these compounds.
    Type: Application
    Filed: December 28, 2011
    Publication date: April 19, 2012
    Inventors: David Bar-Or, C. Gerald Curtis, Nagaraja K.R. Rao, Greg Thomas
  • Uninterruptible Power Supply Systems and Methods for Communications Systems
    Publication number: 20120091811
    Abstract: An uninterruptible power supply for supply electrical power to a load, comprises a connection to a primary source for supplying primary power, a battery system for storing battery power, an inverter, and a controller. The controller controls the inverter to operate in a first mode, a second mode, and in a third mode. In the first mode, power is supplied to the primary load and the battery system based on primary power. In the second mode, power is supplied to the primary load based on battery power. In the third mode, power is supplied to the primary source based on battery power.
    Type: Application
    Filed: October 17, 2011
    Publication date: April 19, 2012
    Applicant: ALPHA TECHNOLOGIES, INC.
    Inventors: Jim Heidenreich, Toby Peck, Craig Paoli, Peter Schmidt, Greg Thomas, John Rodgers
  • METHOD OF USING DIKETOPIPERAZINES AND COMPOSITION CONTAINING THEM
    Publication number: 20120094918
    Abstract: The invention provides a method of inhibiting the effects of platelet activating factor (PAF). For instance, a disease or condition mediated by PAF (particularly inflammation) can be treated or platelet aggregation can be inhibited. The invention also provides a method of inhibiting the production and/or release of interleukin 8 (IL-8) by cells. The effects of PAF and the production and/or release of IL-8 are inhibited according to the invention by a compound of the formula: wherein R1 and R2 are defined in the application, or a physiologically-acceptable salt thereof. The invention also provides pharmaceutical compositions comprising these compounds.
    Type: Application
    Filed: December 27, 2011
    Publication date: April 19, 2012
    Inventors: David Bar-Or, C. Gerald Curtis, Nagaraja K.R. Rao, Greg Thomas
  • METHOD OF USING DIKETOPIPERAZINES AND COMPOSITION CONTAINING THEM
    Publication number: 20120022081
    Abstract: The invention provides a method of inhibiting the effects of platelet activating factor (PAF). For instance, a disease or condition mediated by PAF (particularly inflammation) can be treated or platelet aggregation can be inhibited. The invention also provides a method of inhibiting the production and/or release of interleukin 8 (IL-8) by cells. The effects of PAF and the production and/or release of IL-8 are inhibited according to the invention by a compound of the formula: wherein R1 and R2 are defined in the application, or a physiologically-acceptable salt thereof. The invention also provides pharmaceutical compositions comprising these compounds.
    Type: Application
    Filed: October 4, 2011
    Publication date: January 26, 2012
    Inventors: David Bar-Or, C. Gerald Curtis, Nagaraja K.R. Rao, Greg Thomas
  • METHOD OF USING DIKETOPIPERAZINES AND COMPOSITION CONTAINING THEM
    Publication number: 20120022003
    Abstract: The invention provides a method of inhibiting the effects of platelet activating factor (PAF). For instance, a disease or condition mediated by PAF (particularly inflammation) can be treated or platelet aggregation can be inhibited. The invention also provides a method of inhibiting the production and/or release of interleukin 8 (IL-8) by cells. The effects of PAF and the production and/or release of IL-8 are inhibited according to the invention by a compound of the formula: wherein R1 and R2 are defined in the application, or a physiologically-acceptable salt thereof. The invention also provides pharmaceutical compositions comprising these compounds.
    Type: Application
    Filed: September 29, 2011
    Publication date: January 26, 2012
    Inventors: David Bar-Or, C. Gerald Curtis, Nagaraja K.R. Rao, Greg Thomas
  • Tannate Compositions, Methods of Making and Methods of Use
    Publication number: 20110288079
    Abstract: Tannate compositions containing active pharmaceutical ingredients to be used for treating nausea, vomiting, pain, convulsions, and insomnia and manufacturing processes for preparing the tannate compositions.
    Type: Application
    Filed: July 28, 2011
    Publication date: November 24, 2011
    Inventors: Jeffrey S. Kiel, H. Greg Thomas, Narasimhan ManI
  • Tannate compositions, methods of making and methods of use
    Patent number: 8012506
    Abstract: Tannate compositions containing active pharmaceutical ingredients to be used for treating nausea, vomiting, pain, convulsions, and insomnia and manufacturing processes for preparing the tannate compositions.
    Type: Grant
    Filed: August 9, 2006
    Date of Patent: September 6, 2011
    Assignee: Pernix Therapeutics, LLC
    Inventors: Jeffrey S. Kiel, H. Greg Thomas, Narasimhan Mani
  • Method for doping impurities
    Patent number: 7807556
    Abstract: A method for doping impurities into a device layer includes providing a carbonized dopant layer including one or more dopant impurities over a device layer and heat treating the carbonized dopant layer to thermally diffuse the dopant impurities into the device layer.
    Type: Grant
    Filed: December 5, 2006
    Date of Patent: October 5, 2010
    Assignee: General Electric Company
    Inventors: Greg Thomas Dunne, Jesse Berkley Tucker, Stanislav Ivanovich Soloviev, Zachary Matthew Stum
  • Phenolic acid salts of gabapentin in solid dosage forms and methods of use
    Patent number: 7786168
    Abstract: The present invention relates to pharmaceutical compositions of gabapentin tannate in solid dosage form, processes for production of those compositions and methods of use of those compositions. Tannate salts of active pharmaceutical ingredients are used in sustained release applications and to improve certain organoleptic properties such as taste. The process may utilize either natural or synthetic tannic acid.
    Type: Grant
    Filed: June 13, 2008
    Date of Patent: August 31, 2010
    Assignee: Kiel Laboratories, Inc.
    Inventors: Jeffrey S. Kiel, H. Greg Thomas, Narasimhan Mani
  • METHODS AND SYSTEMS FOR PROVIDING PROGRAMMABLE COMPUTERIZED INTERACTORS
    Publication number: 20100194684
    Abstract: A computerized interactor system uses physical, three-dimensional objects as metaphors for input of user intent to a computer system. When one or more interactors are engaged with a detection field, the detection field reads an identifier associated with the object and communicates the identifier to a computer system. The computer system determines the meaning of the interactor based upon its identifier and upon a semantic context in which the computer system is operating.
    Type: Application
    Filed: April 9, 2010
    Publication date: August 5, 2010
    Applicant: Vulcan Patents LLC
    Inventors: Emily Weil, Greg Thomas, S. Joy Mountford, Thomas J. Dougherty, Daniel E. Cummings
  • Methods and systems for providing programmable computerized interactors
    Patent number: 7724236
    Abstract: A computerized interactor system uses physical, three-dimensional objects as metaphors for input of user intent to a computer system. When one or more interactors are engaged with a detection field, the detection field reads an identifier associated with the object and communicates the identifier to a computer system. The computer system determines the meaning of the interactor based upon its identifier and upon a semantic context in which the computer system is operating.
    Type: Grant
    Filed: August 25, 2005
    Date of Patent: May 25, 2010
    Assignee: Vulcan Patents LLC
    Inventors: Emily Weil, Greg Thomas, S. Joy Mountford, Thomas J. Dougherty, Daniel E. Cummings